Work

Phase I and pharmacokinetic study of irinotecan (CPT-11) administered daily for three consecutive days every three weeks in patients with advanced solid tumors

Year: 1995

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/oxfordjournals.annonc.a059108

Authors: G. Catimel, G.G. Chabot, J.P. Guastalla, A. Dumortier, C. Cote, C. Engel, A. Gouyette, A. Mathieu-Boué, M. Mahjoubi, M. Clavel

Institutions: Centre Léon Bérard, Centre National de la Recherche Scientifique, Institut Gustave Roussy, Laboratoire Babel

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Yakult Honsha, Centre Léon Bérard

OpenAlex ID: W2261826041

FWCI: 4.363

Cites: 35

Cited by: 111

Related to: 10